Methotrexate (MTX) has exhibited anti-cancer activity and has a similar structure to folic acid (FA) with the ability to inhibit dihydrofolate reductase (DHFR), which ultimately impedes the synthesis of deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and protein [7]. This evidence concerns the gene DHFR and cancer.